Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Phase I
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Phase I
BioSpace Movers & Shakers, Oct. 30
Phase I
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Phase I
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Biospace News
-
November 5, 2020
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
Phase I
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Firstwordpharma News
-
October 31, 2020
0
Phase I
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases – FirstWord...
Firstwordpharma News
-
October 31, 2020
0
Phase I
China’s Clover applies for Philippines COVID-19 vaccine trial – FirstWord Pharma
Firstwordpharma News
-
October 31, 2020
0
1
2
3
...
100
Page 1 of 100
- Advertisement -
MOST POPULAR
Amprologix secures funding to develop new antibiotic with Ingenza
February 8, 2019
UPDATE: Pacylex Raises US $3.9 Million To Advance New Cancer Therapy...
March 4, 2020
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for...
May 13, 2019
Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with continued improving...
December 16, 2019
Load more
HOT NEWS
Others
UK regulator unconditionally clears Roche’s purchase of Spark Therapeutics
Commercial
Probiodrug Reports First Quarter 2019 Business Update
Others
AbbVie stops enrolment in all studies of Depatux-M after late-stage failure...
Clinical
Pharmascience Inc. issues voluntary recall of Ranitidine Tablets 75mg, 150mg and...
